The aim of this study was to assess the association between the transforming growth factor-β1 (TGF-β1) gene polymorphisms rs1800469 (commonly known as T-509C) and rs1982073 (commonly known as Leu 10→Pro) and primary vesicoureteral reflux (VUR) and renal scarring. Using a case–control approach, we examined 121 children with primary VUR and 169 controls. Genotyping of the TGF-β1 gene polymorphisms was performed by restriction fragment length polymorphism (RFLP) analysis. The 99mTc-DMSA– or 99mTc-unitiol–single photon emission computed tomography method was used to evaluate renal scars in 84 of 121 VUR children. Statistical analysis revealed differences in rs1800469 genotype frequencies between VUR patients and controls (p = 0.0021). Our data demonstrate that individuals homozygous for the TT genotype are at risk of primary VUR [odds ratio (95% confidence interval) = 2.7 (1.46–5.08)]. Distribution of the rs1982073 polymorphism was similar in VUR children and controls. In terms of renal scarring, patients were stratified into non-scar and scar subgroups, and no differences in the genotype frequencies of either polymorphism was found. Previous reports have shown that the TT genotype of the rs1800469 polymorphism is a risk factor for renal scarring in primary VUR, and the results of our study suggest that this same polymorphism is associated with susceptibility to this congenital uropathy.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358
Border WA, Noble NA (1994) Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286–1292
Ihn H (2002) Pathogenesis of fibrosis: the role of TGF-(beta) and CTGF. Curr Opin Rheumatol 14:681–685
Fujii D, Brissenden JE, Derynck R, Francke U (1986) Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet 12:281–288
Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spetcor TD (1999) Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8:93–97
Shah R, Rahaman B, Hurley CK, Posch P (2006) Allelic diversity in the TGFβ1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 119:61–74
Gou Z, Binswanger U, Knoflach A (2002) Role of codon 10 and codon 25 polymorphisms on TGF-β1 gene expression and protein synthesis in stable renal allograft recipients. Transplant Proc 34:2904–2906
Chow KM, Szeto CC, Poon P, Lau WY, Lai FM, Li PK (2005) Transforming growth factor-β1 gene polymorphism in renal transplant recipients. Ren Fail 27:671–675
Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J, Faffe DS, Shikanai T, Raby BA, Weiss ST, Shore SA (2004) Transforming growth factor beta(1) promoter polymorphism C-509T is associated with asthma. Am J Resp Crit Care Med 169:214–219
Gressner AM, Weiskirchen R, Breitkopf K, Dooley S (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7:d793–d807
Ng DP, Warram JH, Krolewski AS (2003) TGF- beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am J Kidney Dis 41:22–28
Patel A, Scott WR, Lympanyt TA, Rippin JD, Gill GV, Barnett AH, Bain SC, the Warren 3/UK GoKind Study Group (2005) The TGF-β1 gene codon 10 polymprphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. Diabet Med 22:69–73
Salah Khalil M, El Nahas AM, Blakemore AIF (2005) Transforming growth factor-β1 SNPs: genetic and phenotypic correlations in progressive kidney insufficiency. Nephron Exp Nephrol 101:e31–e41
Lahdes-Vasama T, Niskanen K, Rönnholm K (2006) Outcome of kidneys in patients treated for vesicoureteral reflux (VUR) during childhood. Nephrol Dial Transplant 21:2491–2497
Smellie JM, Prescod NP, Shaw PJ, Ridson RA, Bryant TN (1998) Childhood reflux and urinary infections: a follow-up of 10–41 years in 226 adults. Pediatr Nephrol 12:727–736
Mehls O, Rigden S, Ehrich JH, Berthoux F, Jones EHP, Valderrábano F (1996) Report on management of renal failure in Europe XXV, 1994. The child-adult interface. Nephrol Dial Transplant 11:22–23
Cotton SA, Gbadegesin RA, Williams S, Brenchley PEC, Webb NJA (2002) Role of TGF-β1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int 61:61–67
Lee-Chen GJ, Liu KP, Lai YC, Juang HS, Huang SY, Lin CY (2004) Significance of tissue kallikrein promoter and transforming growth factor-β1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int 65:1467–1472
Solari V, Owen D, Puri P (2005) Association of transforming growth factor-β1 gene polymorphism with reflux nephropathy. J Urol 174:1609–1611
Yim HE, Bae IS, Yoo KH, Hong YS, Lee JW (2007) Genetic control of VEGF and TGF-(beta)1 gene polymorphism in childhood urinary tract infection and vesicoureteral reflux. Pediatr Res 62:183–187
International Reflux Study Committee (1981) Medical versus surgical treatment of primary vesicoureteral reflux: a prospective international reflux study in children. J Urol 125:277–283
Ogiński M, Rembelska M (1976) 99mTechnetium-unitiol complex, a new pharmaceutical for kidney scintigraphy. Nuklearmedizin 15:282–286
Gadzicki M, Bieńkiewicz M, Młodkowska E, Knapska M, Kowalewska-Pietrzak M, Kuśmierek J (2004) Cortical scintigraphy in the evaluation of renal defects in children with vesicoureteral reflux — optimization of the procedure and study interpretation. Nucl Med Rev Cent East Eur 7:157–164
Jakobsson B, Svensson L (1997) Transient pyelonephritic changes on 99 m Technetium—dimercaptosuccinic acid scan for at least five months after infection. Acta Pediatr 86:803–807
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Wenneström M, Hansson S, Jodal U, Stockland E (1998) Disappereance of Vesicoureteral Reflux in Children. Arch Pediatr Adolesc Med 152:879–883
The International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851–861
Clark AT, Young RJ, Bertram JF (2001) In vitro studies on the roles of transforming growth factor-β1 in rat metanephric development. Kidney Int 59:1641–1653
Yang SP, Woolf AS, Yuan HT, Scott RJ, Ridson RA, O’Hare MJ, Winyard PJD (2000) Potential biological role of transforming growth factor-β1 in human congenital kidney malformations. Am J Pathol 157:1633–1647
Murawski IJ, Gupta IR (2006) Vesicoureteric reflux and renal malformations: a developmental problem. Clin Genet 69:105–117
Wan J, Greenfield SP, Manyan NG, Zerin M, Ritchey ML, Bloom D (1996) Sibling reflux: a dual centre retrospective study. J Urol 156:677–679
International Reflux Study in Children (1992) Five year study of medical or surgical treatment in children with severe reflux: radiological findings. Pediatr Nephrol 6:223–230
This work was supported by Polish State Committee for Scientific Research grant # 2P05E 01830
About this article
Cite this article
Kowalewska-Pietrzak, M., Klich, I. & Mlynarski, W. TGF-β1 gene polymorphisms and primary vesicoureteral reflux in childhood. Pediatr Nephrol 23, 2195–2200 (2008). https://doi.org/10.1007/s00467-008-0927-6
- Renal scarring
- TGF-β1 gene polymorphisms
- Vesicoureteral reflux